A detailed history of Stifel Financial Corp transactions in Atri Cure, Inc. stock. As of the latest transaction made, Stifel Financial Corp holds 20,221 shares of ATRC stock, worth $562,143. This represents 0.0% of its overall portfolio holdings.

Number of Shares
20,221
Previous 22,572 10.42%
Holding current value
$562,143
Previous $686,000 32.94%
% of portfolio
0.0%
Previous 0.0%

Shares

23 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 13, 2024

SELL
$19.86 - $29.09 $46,690 - $68,390
-2,351 Reduced 10.42%
20,221 $460,000
Q1 2024

May 13, 2024

BUY
$28.21 - $37.78 $66,716 - $89,349
2,365 Added 11.7%
22,572 $686,000
Q4 2023

Feb 12, 2024

BUY
$32.99 - $43.25 $137,535 - $180,309
4,169 Added 25.99%
20,207 $721,000
Q3 2023

Nov 13, 2023

BUY
$41.12 - $57.73 $27,879 - $39,140
678 Added 4.41%
16,038 $702,000
Q2 2023

Aug 14, 2023

SELL
$40.44 - $49.6 $3,801 - $4,662
-94 Reduced 0.61%
15,360 $758,000
Q1 2023

May 12, 2023

BUY
$35.87 - $47.22 $1,255 - $1,652
35 Added 0.23%
15,454 $640,000
Q4 2022

Feb 13, 2023

SELL
$33.48 - $47.45 $47,575 - $67,426
-1,421 Reduced 8.44%
15,419 $684,000
Q3 2022

Nov 14, 2022

SELL
$38.25 - $52.62 $66,402 - $91,348
-1,736 Reduced 9.35%
16,840 $658,000
Q2 2022

Aug 15, 2022

BUY
$35.1 - $66.01 $28,395 - $53,402
809 Added 4.55%
18,576 $759,000
Q1 2022

May 13, 2022

SELL
$57.43 - $71.39 $179,181 - $222,736
-3,120 Reduced 14.94%
17,767 $1.17 Million
Q4 2021

Feb 14, 2022

SELL
$63.4 - $87.14 $38,357 - $52,719
-605 Reduced 2.82%
20,887 $1.45 Million
Q3 2021

Nov 15, 2021

SELL
$69.28 - $84.46 $303,169 - $369,596
-4,376 Reduced 16.92%
21,492 $1.5 Million
Q2 2021

Aug 13, 2021

BUY
$64.13 - $80.18 $127,298 - $159,157
1,985 Added 8.31%
25,868 $2.05 Million
Q1 2021

May 14, 2021

BUY
$53.79 - $66.98 $53,736 - $66,913
999 Added 4.37%
23,883 $1.57 Million
Q4 2020

Feb 12, 2021

BUY
$34.56 - $57.55 $241,747 - $402,562
6,995 Added 44.02%
22,884 $1.27 Million
Q3 2020

Nov 16, 2020

BUY
$38.36 - $46.91 $19,371 - $23,689
505 Added 3.28%
15,889 $634,000
Q2 2020

Aug 14, 2020

SELL
$31.78 - $51.19 $261,835 - $421,754
-8,239 Reduced 34.88%
15,384 $692,000
Q1 2020

May 14, 2020

SELL
$24.49 - $43.84 $57,820 - $103,506
-2,361 Reduced 9.09%
23,623 $789,000
Q4 2019

Feb 13, 2020

BUY
$24.06 - $32.51 $3,103 - $4,193
129 Added 0.5%
25,984 $840,000
Q3 2019

Nov 13, 2019

SELL
$23.81 - $32.52 $88,287 - $120,584
-3,708 Reduced 12.54%
25,855 $645,000
Q2 2019

Aug 14, 2019

BUY
$26.85 - $30.74 $170,497 - $195,199
6,350 Added 27.36%
29,563 $884,000
Q1 2019

May 14, 2019

SELL
$26.38 - $33.34 $114,146 - $144,262
-4,327 Reduced 15.71%
23,213 $623,000
Q4 2018

Feb 13, 2019

BUY
$26.66 - $34.85 $734,216 - $959,769
27,540 New
27,540 $841,000

Others Institutions Holding ATRC

About AtriCure, Inc.


  • Ticker ATRC
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 46,424,700
  • Market Cap $1.29B
  • Description
  • AtriCure, Inc. develops, manufactures, and sells devices for the surgical ablation of cardiac tissue and systems, and intercostal nerves to medical centers in the United States, Europe, Asia, and internationally. The company offers Isolator Synergy Clamps, a single-use disposable radio frequency products; multifunctional pens and linear ablation...
More about ATRC
Track This Portfolio

Track Stifel Financial Corp Portfolio

Follow Stifel Financial Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Stifel Financial Corp, based on Form 13F filings with the SEC.

News

Stay updated on Stifel Financial Corp with notifications on news.